NO20006604L - Fremgangsmåter og transdermale sammensetninger for lindring av smerte - Google Patents
Fremgangsmåter og transdermale sammensetninger for lindring av smerteInfo
- Publication number
- NO20006604L NO20006604L NO20006604A NO20006604A NO20006604L NO 20006604 L NO20006604 L NO 20006604L NO 20006604 A NO20006604 A NO 20006604A NO 20006604 A NO20006604 A NO 20006604A NO 20006604 L NO20006604 L NO 20006604L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- pain relief
- transdermal compositions
- compositions
- amine
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000001412 amines Chemical class 0.000 abstract 2
- 230000002051 biphasic effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Det er beskrevet fremgangsmåter og sammensetninger for transdermal administrering. Det er beskrevet trekk omfattende fremgangsmåter og sammensetninger for transdermal administrering av en amininneholdende forbindelse med bifasisk oppløselighet og/eller et middel som forsterker aktiviteten av den amininneholdende forbindelsen som har bifasisk oppløselighet, for eksempel et muskelavslappende middel, for å lindre smerte.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/106,684 US6290986B1 (en) | 1996-10-24 | 1998-06-29 | Method and composition for transdermal administration of pharmacologic agents |
| US12290399P | 1999-03-05 | 1999-03-05 | |
| PCT/US1999/014653 WO2000000120A1 (en) | 1998-06-29 | 1999-06-29 | Methods and transdermal compositions for pain relief |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20006604D0 NO20006604D0 (no) | 2000-12-22 |
| NO20006604L true NO20006604L (no) | 2001-02-28 |
Family
ID=26803907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006604A NO20006604L (no) | 1998-06-29 | 2000-12-22 | Fremgangsmåter og transdermale sammensetninger for lindring av smerte |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1093348A4 (no) |
| JP (1) | JP2002519310A (no) |
| KR (1) | KR20010078754A (no) |
| CN (1) | CN1331576A (no) |
| AU (1) | AU4841599A (no) |
| BG (1) | BG105175A (no) |
| BR (1) | BR9912508A (no) |
| CA (1) | CA2335837A1 (no) |
| HR (1) | HRP20000905A2 (no) |
| HU (1) | HUP0102728A3 (no) |
| ID (1) | ID28213A (no) |
| IL (1) | IL140420A0 (no) |
| MX (1) | MXPA00012767A (no) |
| NO (1) | NO20006604L (no) |
| PL (1) | PL345216A1 (no) |
| SK (1) | SK20012000A3 (no) |
| TR (1) | TR200003801T2 (no) |
| WO (1) | WO2000000120A1 (no) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6572880B2 (en) * | 1996-10-24 | 2003-06-03 | Pharmaceutical Applications Associates Llc | Methods and transdermal compositions for pain relief |
| ATE289295T1 (de) | 1997-04-22 | 2005-03-15 | Euro Celtique Sa | Die verwendung von durch carbozyklische und heterozyklische reste substituierte semicarbazonen und thiosemicarbazonen als natriumkanalblocker |
| ATE305788T1 (de) | 1999-07-01 | 2005-10-15 | Pharmacia & Upjohn Co Llc | (s,s)-reboxetin zur behandlung von inkontinenz |
| SI1196172T1 (sl) * | 1999-07-01 | 2006-06-30 | Pharmacia & Upjohn Co Llc | (S,S)-reboksetin za zdravljenje kronicne bolecine |
| AU1261501A (en) * | 1999-12-06 | 2001-06-18 | Stanley L. Gore | Compositions and methods for intranasal delivery of active agents to the brain |
| IN191512B (no) * | 2000-01-21 | 2003-12-06 | Panacea Biotech | |
| DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
| NZ524252A (en) * | 2000-07-20 | 2004-03-26 | Lauras As | Cox-2 inhibitors for treating HIV and AIDS |
| DE10042412B4 (de) * | 2000-08-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung |
| US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| EP2218448B1 (en) | 2002-12-13 | 2015-09-23 | Durect Corporation | Oral drug delivery system comprising high viscosity liquid carrier materials |
| JP2005154368A (ja) * | 2003-11-27 | 2005-06-16 | Teikoku Seiyaku Co Ltd | ジソピラミド含有神経因性疼痛の鎮痛剤 |
| JP4807721B2 (ja) * | 2004-01-29 | 2011-11-02 | 株式会社 メドレックス | 消炎鎮痛外用剤 |
| DK2767292T3 (en) | 2004-09-17 | 2016-12-19 | Durect Corp | RENEWABLE local anesthetic COMPOSITION CONTAINING SAIB |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| JP2007308403A (ja) * | 2006-05-17 | 2007-11-29 | Kenji Yoshida | 皮膚外用剤 |
| KR100880748B1 (ko) * | 2006-08-29 | 2009-02-02 | 정헌택 | 디메톡시커큐민을 함유하는 혈관재협착 방지용 조성물 |
| AU2007325918B2 (en) | 2006-11-03 | 2013-10-17 | Durect Corporation | Transdermal delivery systems comprising bupivacaine |
| US9511016B2 (en) * | 2007-06-12 | 2016-12-06 | Epicentrx, Inc. | Topical composition for treating pain |
| EP2067471B1 (en) | 2007-12-06 | 2018-02-14 | Durect Corporation | Oral pharmaceutical dosage forms |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| WO2010128807A2 (ko) * | 2009-05-07 | 2010-11-11 | (주)문엔제이 | 신경손상 및 신경질환 예방 또는 치료용 약학조성물 |
| US8491927B2 (en) | 2009-12-02 | 2013-07-23 | Nimble Epitech, Llc | Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
| CA2905131A1 (en) | 2013-03-15 | 2014-09-18 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| US9446056B2 (en) * | 2014-02-11 | 2016-09-20 | Dr. Reddy's Laboratories Ltd. | Parenteral compositions of celecoxib |
| CN109475505A (zh) | 2016-07-06 | 2019-03-15 | 度瑞公司 | 具有药物组成物、屏障层及药物层的口服剂型 |
| AU2019365255B2 (en) | 2018-10-26 | 2025-06-12 | Viramal Limited | Mucoadhesive gel composition |
| EP3659583B1 (en) | 2018-11-30 | 2023-06-07 | Viramal Limited | A method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent |
| WO2021146215A1 (en) | 2020-01-13 | 2021-07-22 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
| FR3108841B1 (fr) * | 2020-04-06 | 2023-11-03 | Algotherapeutix | Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline |
| CA3203561A1 (en) | 2021-01-12 | 2022-07-21 | Adrian Neil Verity | Sustained release drug delivery systems and related methods |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4395420A (en) * | 1981-12-09 | 1983-07-26 | Bernstein Joel E | Method and composition for treating pruritis |
| SI9300468A (en) * | 1992-10-14 | 1994-06-30 | Hoffmann La Roche | Injectable composition for the sustained release of biologically active compounds |
| GB9315856D0 (en) * | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
| US5654337A (en) * | 1995-03-24 | 1997-08-05 | II William Scott Snyder | Topical formulation for local delivery of a pharmaceutically active agent |
| US5837289A (en) * | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
| US5885597A (en) * | 1997-10-01 | 1999-03-23 | Medical Research Industries,Inc. | Topical composition for the relief of pain |
-
1999
- 1999-06-29 CA CA002335837A patent/CA2335837A1/en not_active Abandoned
- 1999-06-29 BR BR9912508-0A patent/BR9912508A/pt not_active Application Discontinuation
- 1999-06-29 AU AU48415/99A patent/AU4841599A/en not_active Abandoned
- 1999-06-29 EP EP99932017A patent/EP1093348A4/en not_active Withdrawn
- 1999-06-29 JP JP2000556706A patent/JP2002519310A/ja active Pending
- 1999-06-29 KR KR1020007014985A patent/KR20010078754A/ko not_active Withdrawn
- 1999-06-29 TR TR2000/03801T patent/TR200003801T2/xx unknown
- 1999-06-29 CN CN99810055A patent/CN1331576A/zh active Pending
- 1999-06-29 ID IDW20010231A patent/ID28213A/id unknown
- 1999-06-29 HU HU0102728A patent/HUP0102728A3/hu unknown
- 1999-06-29 SK SK2001-2000A patent/SK20012000A3/sk unknown
- 1999-06-29 PL PL99345216A patent/PL345216A1/xx unknown
- 1999-06-29 IL IL14042099A patent/IL140420A0/xx unknown
- 1999-06-29 HR HR20000905A patent/HRP20000905A2/hr not_active Application Discontinuation
- 1999-06-29 MX MXPA00012767A patent/MXPA00012767A/es unknown
- 1999-06-29 WO PCT/US1999/014653 patent/WO2000000120A1/en not_active Ceased
-
2000
- 2000-12-22 NO NO20006604A patent/NO20006604L/no not_active Application Discontinuation
-
2001
- 2001-01-24 BG BG105175A patent/BG105175A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000000120A9 (en) | 2000-03-30 |
| CA2335837A1 (en) | 2000-01-06 |
| ID28213A (id) | 2001-05-10 |
| IL140420A0 (en) | 2002-02-10 |
| HUP0102728A2 (hu) | 2002-03-28 |
| EP1093348A1 (en) | 2001-04-25 |
| EP1093348A4 (en) | 2003-07-16 |
| BG105175A (bg) | 2001-11-30 |
| NO20006604D0 (no) | 2000-12-22 |
| SK20012000A3 (sk) | 2001-08-06 |
| HUP0102728A3 (en) | 2002-12-28 |
| AU4841599A (en) | 2000-01-17 |
| BR9912508A (pt) | 2001-05-02 |
| KR20010078754A (ko) | 2001-08-21 |
| MXPA00012767A (es) | 2002-08-09 |
| TR200003801T2 (tr) | 2001-06-21 |
| PL345216A1 (en) | 2001-12-03 |
| CN1331576A (zh) | 2002-01-16 |
| HRP20000905A2 (en) | 2001-08-31 |
| WO2000000120A1 (en) | 2000-01-06 |
| JP2002519310A (ja) | 2002-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003268144A1 (en) | Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist | |
| WO2002053187A3 (en) | Methods and transdermal compositions for pain relief | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| TR200003801T2 (tr) | Acı hafifletmek için deri üstü kompozisyonlar ve yöntemler | |
| NO20061325L (no) | Kombinasjon av legemidler for behandling av neoplasmer | |
| CY1116464T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
| DK1476141T3 (da) | Manipulationssikrede anordninger til transdermal opioidadministration | |
| BR0212078A (pt) | Método de tratar ou prevenir uma doença relacionada com amilóide em um paciente, composição farmacêutica, composto quìmico, e, uso de um composto | |
| CY1109242T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου | |
| BR0213100A (pt) | Combinações para o tratamento de distúrbios imuniinflamatórios | |
| PT998287E (pt) | Utilizacao de levobupivacaina | |
| EA200001010A1 (ru) | Применение дексмедетомидина для седативного воздействия в отделении интенсивной терапии | |
| NO20024646L (no) | Kombinasjonsterapier med vaskul¶r-skadende aktivitet | |
| DK0904067T3 (da) | Transdermalt indgivet dextromethorpan som hostestillende middel | |
| EP0754457A4 (en) | ACTIVE AGAINST ADDICT | |
| WO2004006849A3 (en) | Combinations of drugs for the treatment of neoplasms | |
| NO20000446D0 (no) | Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser | |
| EA200601249A1 (ru) | Пиперазины, пригодные для лечения боли | |
| ATE536178T1 (de) | Therapeutische anwendung von methionin zur behandlung oder prävention von mucositis | |
| KR950016760A (ko) | 치질 치료제 | |
| WO2004007676A3 (en) | Combination therapy for the treatment of neoplasms | |
| TR200102512T2 (tr) | Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı. | |
| ES2036560T3 (es) | Un metodo para preparar una composicion sinergicamente activa para el tratamiento de hipertension. | |
| EA200400348A1 (ru) | Цисплатиновые составы пониженной токсичности и способы их применения | |
| ATE268170T1 (de) | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |